Event :: How to shape a future EU research and innovation mission on cancer?

On 4 April 2019, the EuroTech Universities Alliance is organising an evening event to discuss a potential future EU research and innovation mission on cancer. In preparation for the potential mission, the EuroTech Universities Alliance has invited a diverse group of leading experts in cancer and health technologies across its member universities to develop some key recommendations. The members of the EuroTech cancer mission think-tank are:

• Douglas Hanahan, Professor and Director of the Swiss Institute for Experimental Cancer Research, EPFL (Chair)
• Sine Reker Hadrup, Professor at Department of Health Technology, DTU
• Alexis Gautreau, Chair of the Biology Department, L’X
• Yuval Shaked, Professor at Faculty of Medicine, Technion and Technion-Israel Integrated Cancer Center
• Jurjen Tel, Assistant Professor in Immuno-engineering, TU/e
• Wolfgang Weber, Professor and Director of the Clinic for Nuclear Medicine, University Hospital Rechts der Isar, TUM.

The recommendations will be presented at the event by Douglas Hanahan, Professor and Director of the Swiss Institute for Experimental Cancer Research, EPFL and Chair of the EuroTech cancer mission think-tank. Prof. Hanahan’s intervention will be followed by specific feedback from key stakeholders in the form of a panel debate and a broader discussion with the audience. The panel will include Isabelle Manneh-Vangramberen, Head of Health and Research Programmes, European Cancer Patient Coalition, and Barbara Kerstiens, Head of Unit for Non Communicable Diseases and the Challenge of Healthy Ageing , DG Research and Innovation at the European Commission.

This is an ‘invitation-only’ event. Should you be interested in attending, please send an e-mail to events@eurotech-universities.eu

In case of questions, please contact Alex van Nieuwland, TU/e Liaison Officer, EuroTech Universities Alliance.

Context:

The EuroTech Universities have a strong track record in research and innovation, receiving EUR 667 million in Horizon 2020 funding and 224 ERC grants between them. Health and bio-engineering represents an important focus area of EuroTech research collaboration for many years. Since the opening of our joint Brussels office in 2012, we have organized regular debates on areas of high relevance to Europe’s leadership in technology.